🧬 SinoBioData Academic Portal
Open AccessDOI: 10.12307/2026.21471Original Research

Main preparation methods of new fluorescent nanomaterial carbon quantum dots and their applications in tumor diagnosis and treatment

Guo Zhiyou¹,Hu Rui¹,Zhu Jinling¹

Jiamusi University

Read Executive PreviewQuick FAQ
Main preparation methods of new fluorescent nanomaterial carbon quantum dots and their applications in tumor diagnosis and treatment
Graphical Abstract / Figure
Published In
Chinese Journal of Tissue Engineering Research
Published:January 15, 2026Edition:Vol 1903, Issue 31 • pp. 100-112Citation:Guo Zhiyou et al. (2026), Chinese Journal of Tissue Engineering Research
Impact FactorPremier Chinese Biomedical Journal indexed in SinoBioData: Chinese Journal of Tissue Engineering Research (中国组织工程研究).
Sponsored Research Partner

Key Takeaways & Executive Findings

  • • Carbon quantum dots (CQDs) are synthesized via top-down (arc discharge, electrochemical, laser ablation) and bottom-up (hydrothermal, microwave, template) methods, with bottom-up offering environmental friendliness and high water solubility. • CQDs serve as fluorescent probes for early tumor diagnosis and real-time monitoring, and their surface modification enables targeted photothermal therapy. • CQDs act as drug carriers for targeted delivery, reducing adverse effects, and in immunotherapy they convert 'cold' tumors to 'hot' tumors by triggering immunogenic cell death and reversing immunosuppression. • Multimodal therapy integrating chemotherapy, phototherapy, and immunotherapy using CQDs achieves high tumor inhibition rates, highlighting their potential for efficient and low-toxicity cancer nanoplatforms.
Sponsored Research Highlight

Abstract

BACKGROUND: Carbon quantum dots are a novel fluorescent nanomaterial that, thanks to their excellent optical properties, good biocompatibility, and low toxicity, show significant potential in the field of tumor diagnosis and treatment. OBJECTIVE: To systematically review the methods used to prepare carbon quantum dots and their applications in tumor diagnosis and treatment. METHODS: Relevant literature was retrieved from the China National Knowledge Infrastructure (CNKI) and PubMed databases using computer searches. Chinese search terms were “tumor therapy, carbon quantum dots, arc discharge, electrochemical discharge, drug delivery, fluorescence imaging.” English search terms were “CQD tumor therapy, carbon quantum dot preparation, carbon quantum dots, tumor diagnosis and treatment.” According to the inclusion and exclusion criteria, 102 articles were finally included in the review. RESULTS AND CONCLUSION: Common preparation methods for carbon quantum dots are top-down method and bottom-up method. In terms of preparation, the top-down method (arc discharge, electrochemical, laser ablation) uses graphite and other carbon materials as precursors, which is simple to operate but produces many by-products and has low quantum yield; after purification, the yield can be improved. The bottom-up method (hydrothermal, microwave, and template) utilizes biomass or small-molecule carbon sources, offering environmental friendliness and excellent water solubility of the products. In tumor diagnosis and therapy, carbon quantum dots exert their effects through multiple synergistic mechanisms. Fluorescence imaging enables early diagnosis and real-time monitoring by labeling tumor cells; photothermal therapy converts light energy into heat to kill tumor cells; photodynamic therapy generates reactive oxygen species to damage tumor cell biomolecules; as drug carriers, carbon quantum dots can target delivery of antitumor drugs to tumor sites, reducing adverse effects; in immunotherapy, they trigger immunogenic cell death, reverse the immunosuppressive microenvironment, and activate the stimulator of interferon genes pathway, converting “cold” tumors to “hot” tumors; in multimodal therapy, carbon quantum dots integrate chemotherapy, phototherapy, and immunotherapy to achieve high tumor inhibition rates.

1. Introduction

Tumors are diseases caused by abnormal proliferation of local tissue cells that have lost normal growth regulation at the genetic level. Despite significant progress in molecular mechanisms of tumor therapy, tumors remain a major threat to human health [1-2]. The treatment modalities vary depending on tumor type, location, nature, and stage; currently, the most effective approaches are surgical resection, radiotherapy, and chemotherapy [3]. Surgical resection is the preferred option for early-stage tumors, but it has time constraints; radiotherapy and chemotherapy, while inhibiting tumor cell division and controlling growth, lack targeting, often damaging normal cells and causing severe side effects [4-5]. Therefore, developing novel nanomaterials that specifically recognize and eliminate tumor cells while minimizing damage to normal tissues is crucial.

Carbon is the most abundant element in nature and has developed rapidly in the field of nanomaterials due to its high stability and wide availability [6]. Among various carbon-based nanomaterials, carbon quantum dots (CQDs) have attracted extensive attention in medicine because of their unique properties [7]. CQDs are near-spherical carbon nanoparticles with sizes less than 10 nm, and their surfaces can be modified with hydrophilic functional groups to achieve excellent water solubility and biocompatibility [8]. CQDs also exhibit excellent fluorescence properties, offering broad application prospects in fluorescence imaging and sensors [9-10]. Moreover, due to the special tumor microenvironment, tumor tissues have enhanced permeability, promoting the accumulation of CQDs, a property known as the enhanced permeability and retention (EPR) effect [11-12]. The EPR effect enhances the tumor targeting of CQDs, and if applied clinically, it is expected to significantly reduce adverse effects of tumor therapy [13]. Compared with traditional heavy metal quantum dots, the toxicity of CQDs is significantly lower [14], further broadening their application prospects in biomedicine.

This review aims to summarize the optimization strategies for CQD preparation (e.g., purification to enhance quantum yield) and their application progress in tumor fluorescence imaging, photothermal/photodynamic therapy, targeted drug delivery, immunomodulation, and multimodal synergistic therapy, with the goal of providing a theoretical basis for developing efficient and low-toxicity tumor theranostic nanoplatforms.

SinoBioData Interactive Document Reader
Page 1–5 of Preview
100%
Download Full PDF

Loading authentic research manuscript (Pages 1–5)...

Sponsored Research Partner
Cite This Research Paper
Guo Zhiyou, Hu Rui, Zhu Jinling (2026). Main preparation methods of new fluorescent nanomaterial carbon quantum dots and their applications in tumor diagnosis and treatment. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21471
SinoBioData Academic & Legal Disclaimer

Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.

Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.

Frequently Asked Questions

What are the main preparation methods for carbon quantum dots?

Carbon quantum dots are prepared via top-down methods (arc discharge, electrochemical, laser ablation) using bulk carbon materials, and bottom-up methods (hydrothermal, microwave, template) using small molecules or biomass. Bottom-up methods are more environmentally friendly and yield products with excellent water solubility.

How do carbon quantum dots contribute to tumor diagnosis?

Carbon quantum dots serve as fluorescent probes that label tumor cells, enabling early diagnosis and real-time monitoring due to their excellent fluorescence properties and biocompatibility.

What therapeutic applications do carbon quantum dots have in oncology?

Carbon quantum dots are used in photothermal therapy (converting light to heat), photodynamic therapy (generating reactive oxygen species), targeted drug delivery (as carriers), immunotherapy (triggering immunogenic cell death and reversing immunosuppression), and multimodal therapy combining multiple approaches.

Why are carbon quantum dots considered advantageous over traditional quantum dots?

Carbon quantum dots exhibit significantly lower toxicity compared to heavy metal quantum dots, along with excellent biocompatibility and water solubility, making them safer for biomedical applications.

What are the current challenges in the clinical application of carbon quantum dots?

Challenges include determining in vivo metabolic kinetics for fluorescence imaging, elucidating in vivo release kinetics for drug delivery, and reducing the risk of systemic immune overactivation in immunotherapy.

Recommended Scientific Literature & Research Partners

Related Technical Papers & Translations

Research Paper
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.

Read Abstract & PDF
Research Paper
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.

Read Abstract & PDF
Research Paper
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.

Read Abstract & PDF